52 results
425
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Business combination disclosure
9:09am
to this Article II, and the Other Party will cooperate and assist in any required communication with any plaintiff or other related third party.
(b
8-K
EX-2.2
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
been allocated pursuant to this Article II, and the Other Party will cooperate and assist in any required communication with any plaintiff or other
8-K
EX-2.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
plaintiff or other related third party.
(b) If the Parties are unable to obtain, or to cause to be obtained, any such required Consent, Governmental